Morgan Stanley’s NeueHealth NEUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3,493
| Closed | -$23.3K | – | 8497 |
|
|
2025
Q3 | $23.3K | Sell |
3,493
-340
| -9% | -$2.29K | ﹤0.01% | 6640 |
|
|
2025
Q2 | $26.4K | Sell |
3,833
-123
| -3% | -$827 | ﹤0.01% | 6562 |
|
|
2025
Q1 | $26.7K | Sell |
3,956
-138
| -3% | -$967 | ﹤0.01% | 6464 |
|
|
2024
Q4 | $30.4K | Sell |
4,094
-136
| -3% | -$721 | ﹤0.01% | 6444 |
|
|
2024
Q3 | $22.1K | Buy |
4,230
+448
| +12% | +$2.37K | ﹤0.01% | 6477 |
|
|
2024
Q2 | $20.6K | Sell |
3,782
-2,592
| -41% | -$15.4K | ﹤0.01% | 6449 |
|
|
2024
Q1 | $41.4K | Buy |
6,374
+2,149
| +51% | +$19.2K | ﹤0.01% | 6291 |
|
|
2023
Q4 | $32.2K | Buy |
4,225
+374
| +10% | +$2.51K | ﹤0.01% | 6304 |
|
|
2023
Q3 | $23K | Buy |
3,851
+1,777
| +86% | +$18.3K | ﹤0.01% | 6436 |
|
|
2023
Q2 | $25.3K | Sell |
2,074
-1,164
| -36% | -$15.4K | ﹤0.01% | 6488 |
|
|
2023
Q1 | $57.1K | Buy |
3,238
+1,277
| +65% | +$65.8K | ﹤0.01% | 6230 |
|
|
2022
Q4 | $102K | Sell |
1,961
-472
| -19% | -$34.3K | ﹤0.01% | 5966 |
|
|
2022
Q3 | $204K | Sell |
2,433
-2,733
| -53% | -$363K | ﹤0.01% | 5716 |
|
|
2022
Q2 | $752K | Buy |
5,166
+1,431
| +38% | +$208K | ﹤0.01% | 5200 |
|
|
2022
Q1 | $577K | Sell |
3,735
-3,223
| -46% | -$716K | ﹤0.01% | 5323 |
|
|
2021
Q4 | $1.92M | Sell |
6,958
-3,098
| -31% | -$1.43M | ﹤0.01% | 4622 |
|
|
2021
Q3 | $6.56M | Buy |
10,056
+9,956
| +9,956% | +$8.76M | ﹤0.01% | 3394 |
|
|
2021
Q2 | $137K | Buy |
+100
| New | +$137K | ﹤0.01% | 6197 |
|
Morgan Stanley's NEUE Position: Q4 2025 in Review
Morgan Stanley sold out of NeueHealth (NEUE) in Q4 2025, closing a stake of 3,493 shares — an estimated $23.3K sold.
Morgan Stanley first reported a position in NEUE in Q2 2021 and held it in 18 quarters. The position peaked at $6.56M in Q3 2021. 0 funds tracked by Wall St. Rank hold NEUE as of Q4 2025.
- Morgan Stanley reported no remaining NeueHealth position as of Q4 2025 after selling out during the quarter.
- Morgan Stanley sold 3,493 NeueHealth shares in Q4 2025, an estimated $23.3K.
- Morgan Stanley first reported a position in NeueHealth in Q2 2021 and held it in 18 quarters.
- Morgan Stanley's NeueHealth position peaked at $6.56M in Q3 2021.
- 0 funds tracked by Wall St. Rank held NeueHealth as of Q4 2025.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.